Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases

Cell Metabolism

Volumn 19, Issue 1, 2014, Pages 21-36

  Spite, Matthew ^a   Clària, Joan ^b   Serhan, Charles N ^c  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; FATTY ACID DERIVATIVE; LIPID; RESOLVINS; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; DIABETES MELLITUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; INFLAMMATION; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; FATTY ACIDS, UNSATURATED; HUMANS; INFLAMMATION; METABOLIC DISEASES;

EID: 84891863253     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.10.006     Document Type: Review

References (127)

1. C.K. Abrass, and M. Hori Alterations in Fc receptor function of macrophages from streptozotocin-induced diabetic rats J. Immunol. 133 1984 1307 1312 (Pubitemid 14060082)
2. A. Ariel, P.L. Li, W. Wang, W.X. Tang, G. Fredman, S. Hong, K.H. Gotlinger, and C.N. Serhan The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering J. Biol. Chem. 280 2005 43079 43086 (Pubitemid 43049274)
3. A. Ariel, G. Fredman, Y.P. Sun, A. Kantarci, T.E. Van Dyke, A.D. Luster, and C.N. Serhan Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression Nat. Immunol. 7 2006 1209 1216 (Pubitemid 44594317)
4. M. Arita, F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N.A. Petasis, and C.N. Serhan Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 J. Exp. Med. 201 2005 713 722 (Pubitemid 40395117)
5. M. Bäck, A. Sultan, O. Ovchinnikova, and G.K. Hansson 5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation Circ. Res. 100 2007 946 949 (Pubitemid 46598919)
6. G.L. Bannenberg, N. Chiang, A. Ariel, M. Arita, E. Tjonahen, K.H. Gotlinger, S. Hong, and C.N. Serhan Molecular circuits of resolution: formation and actions of resolvins and protectins J. Immunol. 174 2005 4345 4355 (Pubitemid 40396017)
7. G. Bedogni, L. Miglioli, F. Masutti, C. Tiribelli, G. Marchesini, and S. Bellentani Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study Hepatology 42 2005 44 52 (Pubitemid 40911310)
8. S. Bohr, S.J. Patel, D. Sarin, D. Irimia, M.L. Yarmush, and F. Berthiaume Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model Wound Repair Regen. 21 2013 35 43
9. E. Börgeson, F.C. McGillicuddy, K.A. Harford, N. Corrigan, D.F. Higgins, P. Maderna, H.M. Roche, and C. Godson Lipoxin A4 attenuates adipose inflammation FASEB J. 26 2012 4287 4294
10. K.E. Bornfeldt, and I. Tabas Insulin resistance, hyperglycemia, and atherosclerosis Cell Metab. 14 2011 575 585
11. S.K. Brancato, and J.E. Albina Wound macrophages as key regulators of repair: origin, phenotype, and function Am. J. Pathol. 178 2011 19 25
12. T.M. Brasky, A.K. Darke, X. Song, C.M. Tangen, P.J. Goodman, I.M. Thompson, F.L. Meyskens Jr., G.E. Goodman, L.M. Minasian, and H.L. Parnes et al. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial J. Natl. Cancer Inst. 105 2013 1132 1141 10.1093/jnci/djt1174
13. C.D. Buckley, D.W. Gilroy, C.N. Serhan, B. Stockinger, and P.P. Tak The resolution of inflammation Nat. Rev. Immunol. 13 2013 59 66
14. P.C. Calder Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br. J. Clin. Pharmacol. 75 2013 645 662
15. R. Cancello, C. Henegar, N. Viguerie, S. Taleb, C. Poitou, C. Rouault, M. Coupaye, V. Pelloux, D. Hugol, and J.L. Bouillot et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss Diabetes 54 2005 2277 2286 (Pubitemid 41134253)
16. C. Canetti, C.H. Serezani, R.G. Atrasz, E.S. White, D.M. Aronoff, and M. Peters-Golden Activation of phosphatase and tensin homolog on chromosome 10 mediates the inhibition of FcgammaR phagocytosis by prostaglandin E2 in alveolar macrophages J. Immunol. 179 2007 8350 8356
17. A.M. Carlin, T.M. Zeni, W.J. English, A.A. Hawasli, J.A. Genaw, K.R. Krause, J.L. Schram, K.L. Kole, J.F. Finks, J.D. Birkmeyer Michigan Bariatric Surgery Collaborative The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity Ann. Surg. 257 2013 791 797
18. M.A. Cassatella The Neutrophil 2003 Karger Basel
19. S.K. Chakrabarti, Y. Wen, A.D. Dobrian, B.K. Cole, Q. Ma, H. Pei, M.D. Williams, M.H. Bevard, G.E. Vandenhoff, and S.R. Keller et al. Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats Am. J. Physiol. Endocrinol. Metab. 300 2011 E175 E187
20. N. Chiang, G. Fredman, F. Bäckhed, S.F. Oh, T. Vickery, B.A. Schmidt, and C.N. Serhan Infection regulates pro-resolving mediators that lower antibiotic requirements Nature 484 2012 524 528
21. N. Chiang, M. Shinohara, J. Dalli, V. Mirakaj, M. Kibi, A.M.K. Choi, and C.N. Serhan Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits J. Immunol. 190 2013 6378 6388
22. J. Clària, J. Dalli, S. Yacoubian, F. Gao, and C.N. Serhan Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat J. Immunol. 189 2012 2597 2605
23. J. Clària, B.T. Nguyen, A.L. Madenci, C.K. Ozaki, and C.N. Serhan Diversity of lipid mediators in human adipose tissue depots Am. J. Physiol. Cell Physiol. 304 2013 C1141 C1149
24. B.K. Cole, D.C. Lieb, A.D. Dobrian, and J.L. Nadler 12- and 15-lipoxygenases in adipose tissue inflammation Prostaglandins Other Lipid Mediat. 104-105 2013 84 92
25. A.G. Cristancho, and M.A. Lazar Forming functional fat: a growing understanding of adipocyte differentiation Nat. Rev. Mol. Cell Biol. 12 2011 722 734
26. J. Dalli, and C.N. Serhan Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators Blood 120 2012 e60 e72
27. J. Dalli, J.W. Winkler, R.A. Colas, H. Arnardottir, C.Y. Cheng, N. Chiang, N.A. Petasis, and C.N. Serhan Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents Chem. Biol. 20 2013 188 201
28. C.P. Day Non-alcoholic fatty liver disease: a massive problem Clin. Med. 11 2011 176 178
29. R. De Caterina n-3 fatty acids in cardiovascular disease N. Engl. J. Med. 364 2011 2439 2450
30. R. Della Bona, M.T. Cardillo, M. Leo, G. Biasillo, M. Gustapane, F. Trotta, and L.M. Biasucci Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role? Inflamm. Res. 62 2013 537 550
31. C.A. Dinarello, A. Simon, and J.W. van der Meer Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases Nat. Rev. Drug Discov. 11 2012 633 652
32. D. El Kebir, P. Gjorstrup, and J.G. Filep Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation Proc. Natl. Acad. Sci. USA 109 2012 14983 14988
33. H.K. Eltzschig, and P. Carmeliet Hypoxia and inflammation N. Engl. J. Med. 364 2011 656 665
34. M.E. Falagas, and M. Kompoti Obesity and infection Lancet Infect. Dis. 6 2006 438 446
35. R.J. Flower Prostaglandins, bioassay and inflammation Br. J. Pharmacol. 147 Suppl 1 2006 S182 S192
36. D.W. Gilroy Resolution of acute inflammation and wound healing C.N. Serhan, P.A. Ward, D.W. Gilroy, Fundamentals of Inflammation 2010 Cambridge University Press New York 17
37. J.W. Godwin, A.R. Pinto, and N.A. Rosenthal Macrophages are required for adult salamander limb regeneration Proc. Natl. Acad. Sci. USA 110 2013 9415 9420
38. A. González-Périz, A. Planagumà, K. Gronert, R. Miquel, M. López-Parra, E. Titos, R. Horrillo, N. Ferré, R. Deulofeu, and V. Arroyo et al. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA FASEB J. 20 2006 2537 2539
39. A. González-Périz, R. Horrillo, N. Ferré, K. Gronert, B. Dong, E. Morán-Salvador, E. Titos, M. Martínez- Clemente, M. López-Parra, V. Arroyo, and J. Clària Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins FASEB J. 23 2009 1946 1957
40. M.F. Gregor, and G.S. Hotamisligil Inflammatory mechanisms in obesity Annu. Rev. Immunol. 29 2011 415 445
41. I. Gukovsky, N. Li, J. Todoric, A. Gukovskaya, and M. Karin Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer Gastroenterology 144 2013 1199 1209 e4
42. R. Gyurko, C.C. Siqueira, N. Caldon, L. Gao, A. Kantarci, and T.E. Van Dyke Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice J. Immunol. 177 2006 7250 7256 (Pubitemid 44715094)
43. C.Z. Han, and K.S. Ravichandran Metabolic connections during apoptotic cell engulfment Cell 147 2011 1442 1445
44. J. Hellmann, Y. Tang, M. Kosuri, A. Bhatnagar, and M. Spite Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice FASEB J. 25 2011 2399 2407
45. J. Hellmann, M.J. Zhang, Y. Tang, M. Rane, A. Bhatnagar, and M. Spite Increased saturated fatty acids in obesity alter resolution of inflammation in part by stimulating prostaglandin production J. Immunol. 191 2013 1383 1392 10.4049/jimmunol.1203369
46. K.J. Ho, M. Spite, C.D. Owens, H. Lancero, A.H. Kroemer, R. Pande, M.A. Creager, C.N. Serhan, and M.S. Conte Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis Am. J. Pathol. 177 2010 2116 2123
47. K.A. Hodgson, J.L. Morris, M.L. Feterl, B.L. Govan, and N. Ketheesan Altered macrophage function is associated with severe Burkholderia pseudomallei infection in a murine model of type 2 diabetes Microbes Infect. 13 2011 1177 1184
48. S. Hong, K. Gronert, P.R. Devchand, R.-L. Moussignac, and C.N. Serhan Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation J. Biol. Chem. 278 2003 14677 14687 (Pubitemid 36799790)
49. R. Horrillo, A. González-Périz, M. Martínez- Clemente, M. López-Parra, N. Ferré, E. Titos, E. Morán-Salvador, R. Deulofeu, V. Arroyo, and J. Clària 5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity J. Immunol. 184 2010 3978 3987
50. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867 (Pubitemid 46024993)
51. J.C. Houck Chemical Messengers of the Inflammatory Process 1979 Elsevier/North-Holland Biomedical Press Amsterdam
52. C.A. Hudert, K.H. Weylandt, Y. Lu, J. Wang, S. Hong, A. Dignass, C.N. Serhan, and J.X. Kang Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis Proc. Natl. Acad. Sci. USA 103 2006 11276 11281 (Pubitemid 44156509)
53. Y. Isobe, M. Arita, S. Matsueda, R. Iwamoto, T. Fujihara, H. Nakanishi, R. Taguchi, K. Masuda, K. Sasaki, and D. Urabe et al. Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid J. Biol. Chem. 287 2012 10525 10534
54. W.J. Jeffcoate, and K.G. Harding Diabetic foot ulcers Lancet 361 2003 1545 1551 (Pubitemid 36566350)
55. J. Jeppesen Low-grade chronic inflammation and vascular damage in patients with rheumatoid arthritis: don't forget "metabolic inflammation" J. Rheumatol. 38 2011 595 597
56. J.E. Kanter, F. Kramer, S. Barnhart, M.M. Averill, A. Vivekanandan-Giri, T. Vickery, L.O. Li, L. Becker, W. Yuan, and A. Chait et al. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1 Proc. Natl. Acad. Sci. USA 109 2012 E715 E724
57. C.L. Karp Links between innate and adaptive immunity C.N. Serhan, P.A. Ward, D.W. Gilroy, Fundamentals of Inflammation 2010 Cambridge University Press New York 28
58. S. Khanna, S. Biswas, Y. Shang, E. Collard, A. Azad, C. Kauh, V. Bhasker, G.M. Gordillo, C.K. Sen, and S. Roy Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice PLoS ONE 5 2010 e9539
59. H.J. Ko, Z. Zhang, D.Y. Jung, J.Y. Jun, Z. Ma, K.E. Jones, S.Y. Chan, and J.K. Kim Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMP-activated protein kinase in the heart Diabetes 58 2009 2536 2546
60. O. Koltsida, S. Karamnov, K. Pyrillou, T. Vickery, A.D. Chairakaki, C. Tamvakopoulos, P. Sideras, C.N. Serhan, and E. Andreakos Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation EMBO Mol Med 5 2013 762 775
61. K. Köröskényi, E. Duró, A. Pallai, Z. Sarang, D. Kloor, D.S. Ucker, S. Beceiro, A. Castrillo, A. Chawla, and C.A. Ledent et al. Involvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation J. Immunol. 186 2011 7144 7155
62. A. Kosicka, A.D. Cunliffe, R. Mackenzie, M.G. Zariwala, M. Perretti, R.J. Flower, and D. Renshaw Attenuation of plasma annexin A1 in human obesity FASEB J. 27 2013 368 378
63. S. Krishnamoorthy, A. Recchiuti, N. Chiang, S. Yacoubian, C.H. Lee, R. Yang, N.A. Petasis, and C.N. Serhan Resolvin D1 binds human phagocytes with evidence for proresolving receptors Proc. Natl. Acad. Sci. USA 107 2010 1660 1665
64. T. Kurihara, C.N. Jones, Y.M. Yu, A.J. Fischman, S. Watada, R.G. Tompkins, S.P. Fagan, and D. Irimia Resolvin D2 restores neutrophil directionality and improves survival after burns FASEB J. 27 2013 2270 2281
65. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat. Immunol. 2 2001 612 619 (Pubitemid 32677628)
66. S. Li, Y. Sun, C.P. Liang, E.B. Thorp, S. Han, A.W. Jehle, V. Saraswathi, B. Pridgen, J.E. Kanter, and R. Li et al. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet Circ. Res. 105 2009 1072 1082
67. C. López-Vicario, A. González-Périz, B. Rius, E. Morán-Salvador, V. García-Alonso, J.J. Lozano, R. Bataller, M. Cofán, J.X. Kang, and V. Arroyo et al. Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis Gut 2013 10.1136/gutjnl-2012-303179
68. C.N. Lumeng, and A.R. Saltiel Inflammatory links between obesity and metabolic disease J. Clin. Invest. 121 2011 2111 2117
69. G. Majno, and I. Joris Cells, Tissues, and Disease: Principles of General Pathology 2004 Oxford University Press New York
70. M. Martínez-Clemente, N. Ferré, A. González- Périz, M. López-Parra, R. Horrillo, E. Titos, E. Morán-Salvador, R. Miquel, V. Arroyo, C.D. Funk, and J. Clària 5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice Hepatology 51 2010 817 827
71. E. Mas, K.D. Croft, P. Zahra, A. Barden, and T.A. Mori Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation Clin. Chem. 58 2012 1476 1484
72. A.J. Merched, K. Ko, K.H. Gotlinger, C.N. Serhan, and L. Chan Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators FASEB J. 22 2008 3595 3606
73. A.J. Merched, C.N. Serhan, and L. Chan Nutrigenetic disruption of inflammation-resolution homeostasis and atherogenesis J Nutrigenet Nutrigenomics 4 2011 12 24
74. T. Miyahara, S. Runge, A. Chatterjee, M. Chen, G. Mottola, J.M. Fitzgerald, C.N. Serhan, and M.S. Conte D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury FASEB J. 27 2013 2220 2232
75. M. Morita, K. Kuba, A. Ichikawa, M. Nakayama, J. Katahira, R. Iwamoto, T. Watanebe, S. Sakabe, T. Daidoji, and S. Nakamura et al. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza Cell 153 2013 112 125
76. D.M. Mosser, and J.P. Edwards Exploring the full spectrum of macrophage activation Nat. Rev. Immunol. 8 2008 958 969
77. P.R. Nagareddy, A.J. Murphy, R.A. Stirzaker, Y. Hu, S. Yu, R.G. Miller, B. Ramkhelawon, E. Distel, M. Westerterp, and L.S. Huang et al. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis Cell Metab. 17 2013 695 708
78. M. Nahrendorf, and F.K. Swirski Monocyte and macrophage heterogeneity in the heart Circ. Res. 112 2013 1624 1633
79. C. Nathan, and A. Ding Nonresolving inflammation Cell 140 2010 871 882
80. A. Neuhofer, M. Zeyda, D. Mascher, B.K. Itariu, I. Murano, L. Leitner, E.E. Hochbrugger, P. Fraisl, S. Cinti, C.N. Serhan, and T.M. Stulnig Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation Diabetes 62 2013 1945 1956
81. M.T. Nguyen, S. Favelyukis, A.K. Nguyen, D. Reichart, P.A. Scott, A. Jenn, R. Liu-Bryan, C.K. Glass, J.G. Neels, and J.M. Olefsky A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways J. Biol. Chem. 282 2007 35279 35292 (Pubitemid 350232441)
82. L.V. Norling, and M. Perretti Control of myeloid cell trafficking in resolution J. Innate Immun. 5 2013 367 376
83. L.V. Norling, M. Spite, R. Yang, R.J. Flower, M. Perretti, and C.N. Serhan Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing J. Immunol. 186 2011 5543 5547
84. B.A. O'Brien, Y. Huang, X. Geng, J.P. Dutz, and D.T. Finegood Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced Diabetes 51 2002 2481 2488 (Pubitemid 34827397)
85. B.A. O'Brien, X. Geng, C.H. Orteu, Y. Huang, M. Ghoreishi, Y. Zhang, J.A. Bush, G. Li, D.T. Finegood, and J.P. Dutz A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse J. Autoimmun. 26 2006 104 115 (Pubitemid 43138880)
86. J.I. Odegaard, and A. Chawla The immune system as a sensor of the metabolic state Immunity 38 2013 644 654
87. D.Y. Oh, S. Talukdar, E.J. Bae, T. Imamura, H. Morinaga, W. Fan, P. Li, W.J. Lu, S.M. Watkins, and J.M. Olefsky GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects Cell 142 2010 687 698
88. J.M. Olefsky, and C.K. Glass Macrophages, inflammation, and insulin resistance Annu. Rev. Physiol. 72 2010 219 246
89. N. Ouchi, J.L. Parker, J.J. Lugus, and K. Walsh Adipokines in inflammation and metabolic disease Nat. Rev. Immunol. 11 2011 85 97
90. M. Perretti, and F. D'Acquisto Annexin A1 and glucocorticoids as effectors of the resolution of inflammation Nat. Rev. Immunol. 9 2009 62 70
91. A. Planagumà, E. Titos, M. López-Parra, J. Gaya, G. Pueyo, V. Arroyo, and J. Clària Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4 FASEB J. 16 2002 1937 1939
92. P. Puri, M.M. Wiest, O. Cheung, F. Mirshahi, C. Sargeant, H.K. Min, M.J. Contos, R.K. Sterling, M. Fuchs, and H. Zhou et al. The plasma lipidomic signature of nonalcoholic steatohepatitis Hepatology 50 2009 1827 1838
93. P. Ramachandran, A. Pellicoro, M.A. Vernon, L. Boulter, R.L. Aucott, A. Ali, S.N. Hartland, V.K. Snowdon, A. Cappon, and T.T. Gordon-Walker et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis Proc. Natl. Acad. Sci. USA 109 2012 E3186 E3195
94. R.N. Redinger Fat storage and the biology of energy expenditure Transl. Res. 154 2009 52 60
95. V.Z. Rocha, and P. Libby Obesity, inflammation, and atherosclerosis Nat Rev Cardiol 6 2009 399 409
96. E.D. Rosen, and B.M. Spiegelman Adipocytes as regulators of energy balance and glucose homeostasis Nature 444 2006 847 853 (Pubitemid 46024991)
97. B. Samuelsson, S.E. Dahlén, J.A. Lindgren, C.A. Rouzer, and C.N. Serhan Leukotrienes and lipoxins: structures, biosynthesis, and biological effects Science 237 1987 1171 1176 (Pubitemid 17131222)
98. S. Schif-Zuck, N. Gross, S. Assi, R. Rostoker, C.N. Serhan, and A. Ariel Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids Eur. J. Immunol. 41 2011 366 379
99. J.M. Schwab, N. Chiang, M. Arita, and C.N. Serhan Resolvin E1 and protectin D1 activate inflammation-resolution programmes Nature 447 2007 869 874 (Pubitemid 46920139)
100. C.N. Serhan A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution Histochem. Cell Biol. 122 2004 305 321 (Pubitemid 39506589)
101. C.N. Serhan Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways Annu. Rev. Immunol. 25 2007 101 137 (Pubitemid 46697904)
102. C.N. Serhan, and N. Chiang Resolution phase lipid mediators of inflammation: agonists of resolution Curr. Opin. Pharmacol. 13 2013 632 640 10.1016/j.coph.2013.1005.1012
103. C.N. Serhan, and N.A. Petasis Resolvins and protectins in inflammation resolution Chem. Rev. 111 2011 5922 5943
104. C.N. Serhan, and J. Savill Resolution of inflammation: the beginning programs the end Nat. Immunol. 6 2005 1191 1197 (Pubitemid 43045627)
105. C.N. Serhan, C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, and K. Gronert Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing J. Exp. Med. 192 2000 1197 1204
106. C.N. Serhan, S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, G. Mirick, and R.-L. Moussignac Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J. Exp. Med. 196 2002 1025 1037 (Pubitemid 35231761)
107. C.N. Serhan, S.D. Brain, C.D. Buckley, D.W. Gilroy, C. Haslett, L.A. O'Neill, M. Perretti, A.G. Rossi, and J.L. Wallace Resolution of inflammation: state of the art, definitions and terms FASEB J. 21 2007 325 332 (Pubitemid 46213480)
108. C.N. Serhan, J. Dalli, S. Karamnov, A. Choi, C.K. Park, Z.Z. Xu, R.R. Ji, M. Zhu, and N.A. Petasis Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain FASEB J. 26 2012 1755 1765
109. J.E. Shaw, and P.W. Ramwell Release of prostaglandin from rat epididymal fat pad on nervous and hormonal stimulation J. Biol. Chem. 243 1968 1498 1503
110. H. Shi, M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier TLR4 links innate immunity and fatty acid-induced insulin resistance J. Clin. Invest. 116 2006 3015 3025 (Pubitemid 44684486)
111. M. Spite, L.V. Norling, L. Summers, R. Yang, D. Cooper, N.A. Petasis, R.J. Flower, M. Perretti, and C.N. Serhan Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis Nature 461 2009 1287 1291
112. M. Spite, J. Hellmann, Y. Tang, S.P. Mathis, M. Kosuri, A. Bhatnagar, V.R. Jala, and B. Haribabu Deficiency of the leukotriene B4 receptor, BLT-1, protects against systemic insulin resistance in diet-induced obesity J. Immunol. 187 2011 1942 1949
113. M.J. Stables, S. Shah, E.B. Camon, R.C. Lovering, J. Newson, J. Bystrom, S. Farrow, and D.W. Gilroy Transcriptomic analyses of murine resolution-phase macrophages Blood 118 2011 e192 e208
114. I. Tabas, and C.K. Glass Anti-inflammatory therapy in chronic disease: challenges and opportunities Science 339 2013 166 172
115. Y. Tang, M.J. Zhang, J. Hellmann, M. Kosuri, A. Bhatnagar, and M. Spite Proresolution therapy for the treatment of delayed healing of diabetic wounds Diabetes 62 2013 618 627
116. H. Tilg, and A.R. Moschen Insulin resistance, inflammation, and non-alcoholic fatty liver disease Trends Endocrinol. Metab. 19 2008 371 379
117. E. Titos, N. Chiang, C.N. Serhan, M. Romano, J. Gaya, G. Pueyo, and J. Clària Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4) Am. J. Physiol. 277 1999 C870 C877
118. E. Titos, B. Rius, A. González-Périz, C. López-Vicario, E. Morán-Salvador, M. Martínez-Clemente, V. Arroyo, and J. Clària Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype J. Immunol. 187 2011 5408 5418
119. P. Trayhurn, and I.S. Wood Signalling role of adipose tissue: adipokines and inflammation in obesity Biochem. Soc. Trans. 33 2005 1078 1081 (Pubitemid 41659117)
120. P.A. Ward Acute and chronic inflammation C.N. Serhan, P.A. Ward, D.W. Gilroy, Fundamentals of Inflammation 2010 Cambridge University Press New York 1
121. C. Weber, A. Zernecke, and P. Libby The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models Nat. Rev. Immunol. 8 2008 802 815
122. H. Wen, D. Gris, Y. Lei, S. Jha, L. Zhang, M.T. Huang, W.J. Brickey, and J.P. Ting Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling Nat. Immunol. 12 2011 408 415
123. C. Wetzler, H. Kämpfer, B. Stallmeyer, J. Pfeilschifter, and S. Frank Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair J. Invest. Dermatol. 115 2000 245 253 (Pubitemid 30637194)
124. P.J. White, M. Arita, R. Taguchi, J.X. Kang, and A. Marette Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice Diabetes 59 2010 3066 3073
125. T.A. Wynn, A. Chawla, and J.W. Pollard Macrophage biology in development, homeostasis and disease Nature 496 2013 445 455
126. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432 (Pubitemid 24365442)
127. L. Zhao, M.P. Moos, R. Gräbner, F. Pédrono, J. Fan, B. Kaiser, N. John, S. Schmidt, R. Spanbroek, and K. Lötzer et al. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm Nat. Med. 10 2004 966 973 (Pubitemid 39273738)